(19)
(11) EP 1 687 020 A1

(12)

(43) Date of publication:
09.08.2006 Bulletin 2006/32

(21) Application number: 04797471.2

(22) Date of filing: 22.11.2004
(51) International Patent Classification (IPC): 
A61K 38/36(2006.01)
A61P 7/00(2006.01)
A61K 38/10(2006.01)
A61P 7/04(2006.01)
(86) International application number:
PCT/DK2004/000810
(87) International publication number:
WO 2005/049070 (02.06.2005 Gazette 2005/22)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 20.11.2003 DK 200301721
23.07.2004 DK 200401141

(71) Applicant: Novo Nordisk Health Care AG
8050 Zürich (CH)

(72) Inventors:
  • ROJKJER, Rasmus
    DK-2820 Gentofte (DK)
  • VIUFF, Dorthe
    DK-2770 Bronshoj (DK)
  • OSTERGAARD, Soren
    DK-2700 Bronshoj (DK)
  • JENSEN, Simon, Bjerregaard
    DK-3400 Hillerod (DK)
  • HANSEN, Jens, Jacob
    DK-4040 Jyllinge (DK)

(74) Representative: Nilsson, Karin Norvin 
Novo Nordisk A/S, Corporate Patents, Novo Allé
2880 Bagsvaerd
2880 Bagsvaerd (DK)

   


(54) THERAPEUTIC USE OF FACTOR XI